SEARCH

SEARCH BY CITATION

Keywords:

  • liver transplantation;
  • children;
  • de novo HBV infection;
  • hepatitis B;
  • tenofovir;
  • lamivudine;
  • combined antiviral therapy

Abstract

The management of de novo hepatitis B (HBV) infection in children after liver transplantation is not well defined. Because this infection may induce severe liver disease in the graft liver, an efficient antiviral therapy is desirable. Here, we describe the favorable viral outcome observed in a liver transplanted girl with de novo HBV infection following combination therapy with lamivudine and tenofovir.